The electronic absorption (UV) to circular dichroism (CD) signal ratio can be used for enantiomeric excess (ee) analysis within linear range. However, CD detection often requires a high sample concentration where deviations from Beer's law may occur. Individual enantiomers of four chiral compounds were separated from commercial racemates by semipreparative high-performance liquid chromatography (HPLC) with chiral columns. They were used to trace possible deviations in both UV and CD detection on achiral HPLC with a photodiode array detector and a CD detector. The CD/UV ratios for samples with the same ee value decreased by up to 7.8 to 52% when the injection volume increased, indicating that the linear standard curve of ee versus CD/UV is only valid within a narrow range. To extend the sample amount to a wider range, a data-processing method was developed based on two second-order polynomial functions, which were constructed to fit the relationship between the intensities of the UV and CD signals for two enantiomers. Moreover, a more simplified method based on a third-order polynomial function was established to calculate the ee values. The variations between the predicted and experimental ee values were within +/- 0.08 for both methods. To our knowledge, this is the first study that the deviations from Beer's law are considered in both UV and CD detection for ee analysis.
机构:
Shenyang Pharmaceut Univ, Shenyang 110016, Peoples R ChinaShenyang Pharmaceut Univ, Shenyang 110016, Peoples R China
Song, Shuang
Sun, Lu
论文数: 0引用数: 0
h-index: 0
机构:
Shenyang Pharmaceut Univ, Shenyang 110016, Peoples R ChinaShenyang Pharmaceut Univ, Shenyang 110016, Peoples R China
Sun, Lu
Yuan, Lei
论文数: 0引用数: 0
h-index: 0
机构:
Shenyang Pharmaceut Univ, Shenyang 110016, Peoples R ChinaShenyang Pharmaceut Univ, Shenyang 110016, Peoples R China
Yuan, Lei
Sun, Tieniin
论文数: 0引用数: 0
h-index: 0
机构:
Shenyang Pharmaceut Univ, Shenyang 110016, Peoples R ChinaShenyang Pharmaceut Univ, Shenyang 110016, Peoples R China
Sun, Tieniin
Zhao, Yun
论文数: 0引用数: 0
h-index: 0
机构:
Shenyang Pharmaceut Univ, Shenyang 110016, Peoples R ChinaShenyang Pharmaceut Univ, Shenyang 110016, Peoples R China
Zhao, Yun
Zuo, Wenjian
论文数: 0引用数: 0
h-index: 0
机构:
Shenyang Pharmaceut Univ, Shenyang 110016, Peoples R ChinaShenyang Pharmaceut Univ, Shenyang 110016, Peoples R China
Zuo, Wenjian
Cong, Yue
论文数: 0引用数: 0
h-index: 0
机构:
Shenyang Pharmaceut Univ, Shenyang 110016, Peoples R ChinaShenyang Pharmaceut Univ, Shenyang 110016, Peoples R China
Cong, Yue
Li, Xian
论文数: 0引用数: 0
h-index: 0
机构:
Shenyang Pharmaceut Univ, Shenyang 110016, Peoples R ChinaShenyang Pharmaceut Univ, Shenyang 110016, Peoples R China
Li, Xian
Wang, Jinhui
论文数: 0引用数: 0
h-index: 0
机构:
Shenyang Pharmaceut Univ, Shenyang 110016, Peoples R China
Shihezi Univ, Shihezi 832002, Peoples R ChinaShenyang Pharmaceut Univ, Shenyang 110016, Peoples R China
机构:Peking Union Med Coll, Beijing Key Lab Act Subst Discovery & Druggabil E, State Key Lab Bioact Subst & Funct Nat Med, Inst Mat Med, Beijing, Peoples R China
Zhang, Xiang
Wang, Mingchao
论文数: 0引用数: 0
h-index: 0
机构:Peking Union Med Coll, Beijing Key Lab Act Subst Discovery & Druggabil E, State Key Lab Bioact Subst & Funct Nat Med, Inst Mat Med, Beijing, Peoples R China
Wang, Mingchao
Li, Li
论文数: 0引用数: 0
h-index: 0
机构:
Peking Union Med Coll, Beijing Key Lab Act Subst Discovery & Druggabil E, State Key Lab Bioact Subst & Funct Nat Med, Inst Mat Med, Beijing, Peoples R ChinaPeking Union Med Coll, Beijing Key Lab Act Subst Discovery & Druggabil E, State Key Lab Bioact Subst & Funct Nat Med, Inst Mat Med, Beijing, Peoples R China
Li, Li
Yin, Dali
论文数: 0引用数: 0
h-index: 0
机构:
Peking Union Med Coll, Beijing Key Lab Act Subst Discovery & Druggabil E, State Key Lab Bioact Subst & Funct Nat Med, Inst Mat Med, Beijing, Peoples R ChinaPeking Union Med Coll, Beijing Key Lab Act Subst Discovery & Druggabil E, State Key Lab Bioact Subst & Funct Nat Med, Inst Mat Med, Beijing, Peoples R China